📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
0
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BEKE.
💹 Market Data
Market Cap$18.24B
Shares Outstanding1.07B
Float1.12B
Cash$6.65B
Debt$2.40B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 18.2% shares (2025Q4 vs prior)
228 institutional holders · 203.42M shares
#1
VANGUARD GROUP INC
25.75M shares
#2
PRICE T ROWE ASSOCIATES INC /MD/
12.18M shares
#3
JANE STREET GROUP, LLC
10.24M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest24.12M
Days to Cover5.8
% of Float2.8%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2020
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BEKE
📊 BEKE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BEKE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.